SEARCH · PubMed Health

Results for “Particle Accelerators”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,567 records · Page 87Linked to original sources

PubMed2002

Accelerator mass spectrometry at Arizona: geochronology of the climatic record and connections with the ocean.

There are many diverse uses of accelerator mass spectrometry (AMS). 14C studies at our laboratory include much research related to paleoclimate, with 14C as a tracer of past changes in environmental conditions as observed in corals, marine sediments, and many terrestrial records. Terrestrial records can also show the influence of oceanic oscillations, whether they are short term, such as ENSO (El Niño/Southern Oscillation), or on the millennial time scale. In tracer applications, we have developed the use of 129I as well as 14C as tracers for nuclear pollution studies around radioactive waste dump sites, in collaboration with IAEA. We discuss some applications carried out in Tucson, AZ, for several of these fields and hope to give some idea of the breadth of these studies.

Archaeology↗

PubMed2001

Characterization of a commercial multileaf collimator used for intensity modulated radiation therapy.

The characteristics of a commercial multileaf collimator (MLC) to deliver static and dynamic multileaf collimation (SMLC and DMLC, respectively) were investigated to determine their influence on intensity modulated radiation therapy (IMRT) treatment planning and quality assurance. The influence of MLC leaf positioning accuracy on sequentially abutted SMLC fields was measured by creating abutting fields with selected gaps and overlaps. These data were also used to measure static leaf positioning precision. The characteristics of high leaf-velocity DMLC delivery were measured with constant velocity leaf sequences starting with an open field and closing a single leaf bank. A range of 1-72 monitor units (MU) was used providing a range of leaf velocities. The field abutment measurements yielded dose errors (as a percentage of the open field max dose) of 16.7+/-0.7% mm(-1) and 12.8+/-0.7% mm(-1) for 6 MV and 18 MV photon beams, respectively. The MLC leaf positioning precision was 0.080+/-0.018 mm (single standard deviation) highlighting the excellent delivery hardware tolerances for the tested beam delivery geometry. The high leaf-velocity DMLC measurements showed delivery artifacts when the leaf sequence and selected monitor units caused the linear accelerator to move the leaves at their maximum velocity while modulating the accelerator dose rate to deliver the desired leaf and MU sequence (termed leaf-velocity limited delivery). According to the vendor, a unique feature to their linear accelerator and MLC is that the dose rate is reduced to provide the correct cm MU(-1) leaf velocity when the delivery is leaf-velocity limited. However, it was found that the system delivered roughly 1 MU per pulse when the delivery was leaf-velocity limited causing dose profiles to exhibit discrete steps rather than a smooth dose gradient. The root mean square difference between the steps and desired linear gradient was less than 3% when more than 4 MU were used. The average dose per MU was greater and less than desired for closing and opening leaf patterns, respectively, when the delivery was leaf-velocity limited. The results indicated that the dose delivery artifacts should be minor for most clinical cases, but limit the assumption of dose linearity when significantly reducing the delivered dose for dosimeter characterization studies or QA measurements.

Humans↗

PubMedDate not supplied

Photonuclear activation ratios in fluorine compounds; an index of bremsstrahlung quality.

Samples of potassium hexafluorosilicate (K2SiF6) and polytetrafluoroethylene (C2F4)n were irradiated in the bremsstrahlung beam from a clinical linear electron accelerator at integral values of endpoint energy between 13 and 32 MeV. Sample positron activities produced by the reactions 39K(gamma, n) 38K, 19F(gamma, n) 18F, and 12C(gamma, n)11C, were determined by counting the gamma radiation. Saturation activities per target nucleus were calculated from these data. For the K2SiF6 samples, the photonuclear activation ratio (PAR) of the 7.6 min 39K saturation activity per nucleus divided by the 18F result increased by more than 20% per MeV between 15 and 21 MeV. For the (C2F4)n samples the ratio (PAR) of the 11C saturation activity per nucleus to that for 18F increased by more than 24% per MeV between 22 and 26 MeV. Quality changes caused by the lead flattening filter were easily detectable using the PAR technique. Because of the high sensitivity to bremsstrahlung spectrum changes these PAR values can serve as sensitive indices of quality for high-energy beams.

Fluorides↗

PubMed2003

LET and ion-species dependence for cell killing and mutation induction in normal human fibroblasts.

We have been studying LET and ion species dependence of RBE values in cell killing and mutation induction. Normal human skin fibroblasts were irradiated with heavy-ion beams such as carbon (290 Mev/u and 135 Mev/u), neon (230 Mev/u and 400 Mev/u), silicon (490 Mev/u) and iron (500 Mev/u) ion beams, generated by Heavy Ion Medical Accelerator in Chiba (HIMAC) at National Institute of Radiological Sciences (NIRS). Cell killing effect was detected as reproductive cell death using a colony formation assay. Mutation induction in hprt locus was detected to measure 6-thioguanine resistant colonies. The RBE-LET curves of cell killing and mutation induction were different each ion beam. So, we plotted RBE for cell killing and mutation induction as function of Z*2/beta2 instead of LET. RBE-Z*2/beta2 curves of cell killing indicated that the discrepancy of RBE-LET curves was reconciled each ion species. But RBE-Z*2/beta2 curves of mutation induction didn't corresponded between carbon- and silicon-ion beams. These results suggested that different biological endpoints may be suitable for different physical parameter, which represent the track structure of energy deposition of ion beams.

Carbon↗

PubMedDate not supplied

Dosimetric characterization of the 18-MV photon beam from the Siemens Mevatron 77 linear accelerator.

A comprehensive set of dosimetric measurements has been made on the Mevatron 77.80.67 18-MV photon beam. Percentage depth dose, dose in the buildup region, field size dependence of output, transmission through lead, tray attenuation, and isodose curves for the open and wedged fields were measured using an ionization chamber in water and polystyrene phantoms. These dosimetric measurements sufficiently characterized the beam to permit clinical use. The depth dose at 10-cm depth for a 10 X 10 cm2 field at 100-cm source-to-skin distance (SSD) is 80.9%, which meets design specifications. Central axis depth-dose data were fitted to within 0.5% by a set of polynomial equations utilizing a two-dimensional linear regression analysis. Tissue-maximum ratios calculated from depth-dose data agree with measured data to within 2%. Output differences as large as 2.5% were measured for rectangular fields depending on which collimator jaws defined the long dimension of the field. The field size dependence of output was fit to within +/- 0.1% by a linear regression. The half-value thickness of the beam was measured to be 13 mm of lead.

Models, Structural↗

PubMed2004

In vivo release from a drug delivery MEMS device.

A drug delivery microelectromechanical systems (MEMS) device was designed to release complex profiles of multiple substances in order to maximize the effectiveness of drug therapies. The device is based on micro-reservoirs etched into a silicon substrate that contain individual doses of drug. Each dose is released by the electrochemical dissolution of the gold membrane that covers the reservoir. The first in vivo operation of this device was reported in this study. Subcutaneous release was demonstrated in rats using two tracer molecules, fluorescein dye and radiolabeled mannitol, and one radiolabeled chemotherapeutic agent, carmustine (BCNU). BCNU was chosen because of the need to improve the direct delivery of chemotherapy to malignant tumors. The spatial profile of fluorescein dye release from the drug delivery device was evaluated by fluorimetry, the temporal profile of 14C labeled mannitol release was evaluated by liquid scintillation counting, and the temporal profile of 14C labeled BCNU release was evaluated by accelerator mass spectrometry (AMS). Release profiles obtained from injected controls were compared with those from activated devices. The in vivo dye release results showed high concentration of fluorescein in the flank tissue surrounding the devices 1 h after activation. The 14C labeled mannitol released from the drug delivery devices was rapidly cleared (1 day) from the rat urine. In vivo release of 14C labeled BCNU from activated devices showed slightly slower kinetics than the injected and in vitro controls, and the time to reach the steady-state plasma 14C concentration was on the order of 1 h. All these results demonstrated the capability of this drug delivery device to achieve localized delivery of various compounds with well-defined temporal profiles.

Animals↗

PubMedDate not supplied

Fixed bending current for Elekta SL25 linear accelerators.

In a medical linear accelerator a bending magnet is used to bend the electron beam produced by the accelerator tube, in the treatment direction. For each electron energy the strength of the magnetic field has to be set to a specific level. Changing the magnetic field strength is done by changing the electric current through the bending magnet. When electron energy and magnetic field strength are not matched, performance of the linac can be affected. As electron energy, magneticfield strength and electrical current through the bending magnet are related to each other, it is reasonable to assume that for each electron energy the correct bending current can be predetermined. This calculated bending current reduces the number of variable parameters used to set up a treatment beam. Predetermining a variable simplifies the tuning procedures. It also prevents a deviation of the electron beam energy being compensated by variation of the bending current. Preventing false machine settings can contribute to increase linac performance and reduce down time and cost of ownership.

Calibration↗

PubMed1999

Design for an accelerator-based orthogonal epithermal neutron beam for boron neutron capture therapy.

This paper is concerned with the proposed Birmingham accelerator-based epithermal neutron beam for boron neutron capture therapy (BNCT). In particular, the option of producing a therapy beam at an orthogonal direction to the incoming protons is considered. Monte Carlo radiation transport simulations, both with and without a head phantom, have shown that an orthogonal beam geometry is not only acceptable but is indeed beneficial, in terms of a lower mean neutron energy and an enhanced therapeutic ratio for the same useful neutron fluence in the therapy beam. Typical treatment times for various beam options have been calculated, and range from 20 to 48 min with a 5 mA beam of 2.8 MeV protons, if the maximum photon-equivalent dose delivered to healthy tissue is to be 12.6 Gy Eq. The effects of proton beam diameter upon the therapy beam parameters have also been considered.

Boron Neutron Capture Therapy↗

PubMed1990

Verification of electron beam therapy with storage phosphor images: precision of field placement.

Portal verification images were generated from the photon contamination in electron beams produced by a linear accelerator during treatment of patients receiving high-energy electron radiation therapy (8-14 MeV). An experimental storage phosphor system was used to record the images and display them on laser-printed film. Images were obtained from four or more treatment fractions from 21 cases of head and neck cancer. Precision in field placement was estimated by determining the position of a selected anatomic landmark relative to the center of the field for each series of images. The average standard deviation in the field-position measurements was 3.8 mm. Several procedural problems were also detected and corrected after review of the verification images. The results indicate that the emphasis placed on monitoring and control of field-positioning error in high-energy electron treatments should be similar to the emphasis placed on this aspect of error in photon treatment.

Electrons↗

PubMed1991

Electron beam effective source surface distances for a high energy linear accelerator.

The design of the Varian Clinac 1800 linear accelerator electron applicator system does not allow clearance for all head and neck patients to be treated at the standard calibration distance of 100 cm. Discrepancies have been found between dose calculations using the inverse square law for extended distances and their measured data. A 4 X 4 cm2 applicator at an energy of 9 MeV, for example, had dose differences of 13 and 23% at distances of 105 and 110 cm SSD. Because of these discrepancies, effective source surface distances (SSDeff) were determined for all the standard electron energies and applicators of a Clinac 1800. These effective source surface distances ranged from 41.6 cm to 92.6 cm for the 4 X 4 cm2 cone/6 MeV electron beam through the 25 X 25 cm2 cone/20 MeV electron beam. A summary of these distances and an analysis of the clinical use of both a best fit SSDeff and a common SSDeff for patient dosimetry calculations is presented.

Calibration↗

PubMed2003

Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources.

PURPOSE: To assess the state of our specialty, the Spanish Society of Radiotherapy and Oncology ordered a survey of all Spanish services of radiation oncology. METHODS AND MATERIALS: In June 1999, the Society ordered an analysis of the state of radiation oncology. It created a survey that was sent to all radiotherapy units in Spain. A database was created in which 230 variables were analyzed. RESULTS: Eighty-four centers were analyzed, and 157 external beam irradiation, megavoltage units were counted, of which 67 were cobalt units and 90 were linear accelerators. The cobalt units worked an average of 11.4 h daily and the linear accelerators 11.6 h. The number of patients/unit/y was 472 for the cobalt units and 442 for the linear accelerators. The number of patients by physician and year was 179. Each center received a mean of 958 new patients annually. The average between the reception and start of treatment was 25.52 days (maximum 60), and it was estimated that only 38.1% of cancers were irradiated. The number of radiation oncologists working was 392. Spain has a deficit of 297 radiation oncologists. CONCLUSION: There is a need for 44 MV units and for the replacement of 67 cobalt units. The present lack of units has had an impact on palliative treatment, which has resulted in pharmacy costs. As long as these instrumental deficiencies are not solved, waiting lists will continue to be inherent to the system. There are also important staff deficiencies, in that about 297 radiation oncologists would be needed to cover the needs.

Health Services Needs and Demand↗

PubMed1987

The in-air scattering of clinical electron beams as produced by accelerators with scanning beams and diaphragm collimators.

The electron distribution F(x, y, z, theta x, theta y) in air has been evaluated for a clinical electron beam emanating from a scanning beam accelerator in which the collimation of the beam is performed by means of diaphragm collimators. The multiple scattering theory of Fermi turns out to be adequate in describing this electron distribution. In this theory, the only parameter to be determined experimentally is the angular variance at the level of the collimator blocks. Generally, this angular variance features the same energy dependence as the angular scattering power and its value at an arbitrary energy can be derived from measuring the penumbra widths of off-axis profiles in air, at various distances beyond the collimator blocks. Then, the angular variance at the level of a secondary diaphragm collimator can be calculated, as well as off-axis profiles in air at arbitrary distances. In this way, the relative electron distribution at the surface of patients can be calculated easily. This in turn serves adequately as input to the calculation of patient dose distributions in radiation therapy planning.

Air↗

PubMed2000

Verification of absolute dose rates for intravascular brachytherapy beta sources.

The absolute dose rate around beta sources for intravascular brachytherapy was measured with thin thermoluminescent (TL) dosimeters and radiochromic film. The calibration of these dosimeters was performed at the dose maximum in a 6 MeV electron beam of a linear accelerator. Compared to the values given by the manufacturers, higher dose rates of about 20% for 90Sr/90Y source trains and 20 to 40% for 90Y line sources were found. We also measured the dose rate for a planar 90Sr/90Y source, which was calibrated at NIST (National Institute of Standards and Technology). This source serves as a reference for the determination of the dose rates by the supplier of the 90Y sources. For this source we measured a 13% higher dose rate compared to the value given in the calibration report by NIST. Our observation can have important consequences for the interpretation and comparison of the dose-related clinical results of intravascular brachytherapy with these and other beta sources. Also the comparison of the clinical results obtained with beta sources and gamma sources, i.e. 192Ir, depends largely on the accuracy of the absolute dosimetry of the beta sources.

Blood Vessels↗

PubMed2005

High-precision dosimetry for radiotherapy using the optically stimulated luminescence technique and thin Al2O3:C dosimeters.

The potential of using the optically stimulated luminescence (OSL) technique with aluminium oxide (Al(2)O(3):C) dosimeters for a precise and accurate estimation of absorbed doses delivered by high-energy photon beams was investigated. This study demonstrates the high reproducibility of the OSL measurements and presents a preliminary determination of the depth-dose curve in water for a 6 MV photon beam from a linear accelerator. The uncertainty of a single OSL measurement, estimated from the variance of a large sample of dosimeters irradiated with the same dose, was 0.7%. In the depth-dose curve obtained using the OSL technique, the difference between the measured and expected doses was < or =0.7% for depths between 1.5 and 10 cm, and 1.1% for a depth of 15 cm. The readout procedure includes a normalization of the response of the dosimeter with respect to a reference dose in order to eliminate variations in the dosimeter mass, dosimeter sensitivity, and the reader's sensitivity. This may be relevant for quality assurance programmes, since it simplifies the requirements in terms of personnel training to achieve the precision and accuracy necessary for radiotherapy applications. We concluded that the OSL technique has the potential to be reliably incorporated in quality assurance programmes and dose verification.

Aluminum Oxide↗

PubMed2006

Neutron production from a mobile linear accelerator operating in electron mode for intraoperative radiation therapy.

Intraoperative electron beam radiotherapy is increasingly performed using mobile linac delivering therapeutic radiation doses in unshielded operating rooms. While no special neutron-shielding problem should arise for operation at 10 MeV or less, it is not clear whether this holds true for operation at higher energies. This paper reports the measured neutron production from a Mobetron mobile electron linac, operated at 12 MeV, and compares the results with those from a conventional linac, also operated at 12 MeV in electron mode. Neutron leakage measurements were performed by means of passive bubble detectors in the scattering foil, patient and floor planes. Neutron dose equivalent rates per unit of electron dose delivered by the Mobetron at its normal treatment distance (50 cm SSD) were 0.33 microSv Gy(-1) at the accelerator head, 0.18 microSv Gy(-1) in the patient plane at 15 cm from the beam axis and 0.31 microSv Gy(-1) at the floor plane, on the beam axis and under the beam stopper. For a weekly workload of 250 Gy, the weekly neutron dose equivalents at 12 MeV for the Mobetron at a distance of 300 cm from the scattering foil were 14.3 and 1.7 microSv/week for floor below and adjoining areas on the same floor, respectively. Neutron dose equivalent rates generated from Mobetron are at least one order of magnitude lower than ones produced by a conventional linac operated at the same energy in electron mode. Mobetron can be used at 12 MeV in an unshielded operating room for a weekly workload of up to 250 Gy if the bremsstrahlung x-rays are shielded to negligible levels.

Combined Modality Therapy↗

PubMed2001

Image display for collision avoidance of radiation therapy: treatment planning.

Patient treatment in a medical linear accelerator is characterized by many angular and translational movements of the gantry and couch. The direction and orientation of each treatment beam is specified by a set of gantry, turntable, and collimator angles. It is possible that some selected treatment field configurations will result in gantry/couch or gantry/patient collisions that remain undetected during the treatment planning process. In this work, a digital camera has been used to record all the workable gantry/ patient set-up images, and a Windows programming language is used to edit and display these images on a personal computer for the treatment planner to screen the treatment plans. These graphical displays enable the planner to be aware of any potential collision hazards by an actual visualization of each selected gantry/turntable or gantry/patient angle configuration.

Accident Prevention↗

PubMed1996

Comparison of measured and calculated dose for asymmetric x-ray beams defined by independently movable collimators.

Linear accelerators with x-ray collimators that move independently are becoming increasingly common for treatment with asymmetric fields. In an asymmetric field, the center of the treatment field is away from the true central axis where dosimetric data are normally obtained. In this paper we present a simplified approach to the calculation of dose for asymmetric fields. We use central axis tissue-maximum ratio, off-axis factor in phantom and relative field-size factor in phantom to calculate dose. The accuracy of our calculations has been compared with ion-chamber measurements for 6 and 15 MV x-ray beams. Measurements were made at 5, 10, and 15 cm off-axis for a 20 cm x 20 cm asymmetric field at dmax and 6 cm depths in a solid-water phantom using a 0.6 cc Farmer chamber. Agreement within 3% was found at the measurement points.

Equipment Design↗

PubMed2004

Neutron field measurements for alara purposes around a Van de Graaff accelerator building.

The Institute for Reference Materials and Measurements operates a 7.0 MV Van de Graaff accelerator to generate monoenergetic neutron radiation for experimental applications. Owing to increased intensities of generated neutron fields and the more stringent regulation related to the maximum dose for the public, a concrete shielding wall surrounding the experimental building was constructed. This paper presents a study aiming at evaluating the effect of the shielding on the neutron field outside the wall. For this purpose, the following measurements were carried out around the building: (1) cartography of the neutron field for different experimental conditions; (2) measurement of neutron spectra using multiple Bonner spheres; (3) activation measurements using gold discs followed by low-level gamma spectrometry. From the measurements, it can be concluded that the wall fulfils its purpose to reduce the neutron dose rate to the surrounding area to an acceptable level.

Air Pollution, Indoor↗